Recalls / Active ingredient / Olmesartan Medoxomil
Olmesartan Medoxomil
6 FDA drug recalls involving the active ingredient “Olmesartan Medoxomil”.
| Date | Class | Product | Firm |
|---|---|---|---|
| 2025-07-21 | Class II | Amlodipine and Olmesartan Medoxomil Tablets, 5 mg/ 40 mg, 30-count bottle, Rx Only, Manufactured by: Alkem Lab | Ascend Laboratories, LLC |
| 2022-02-15 | Class II | Amlodipine and Olmesartan Medoxomil Tablets, 10 mg /20 mg, 30-count bottles, Rx only, Manufactured for: Macleo | Macleods Pharma Usa Inc |
| 2021-04-29 | Class III | Olmesartan Medoxomil Tablets, USP, 20 mg, Rx Only, 30 Tablets, Manufactured by Alkem Laboratories Ltd, Mumbai, | Ascend Laboratories LLC |
| 2021-03-15 | Class II | Amlodipine and Olmesartan Medoxomil Tablets 10 mg/20 mg 30 Tablets Rx Only NDC 33342-192-07 Manufactured for: | Cardinal Health Inc. |
| 2020-01-24 | Class II | Olmesartan Medoxomil Tablets 20 mg, Rx Only, 90 Tablets per Bottle, Manufactured by: Alkem Laboratories Ltd., | Ascend Laboratories LLC |
| 2018-11-30 | Class III | Amlodipine and Olmesartan Medoxomil Tablets, 5 mg/40 mg, Rx only, 30-count bottle, Distributed by: Aurobindo P | Aurobindo Pharma USA Inc. |